Cover Image
市場調查報告書

FirstString Research, Inc.- 產品平台檢討

FirstString Research, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293902
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
FirstString Research, Inc.- 產品平台檢討 FirstString Research, Inc. - Product Pipeline Review - 2015
出版日期: 2015年05月29日 內容資訊: 英文 23 Pages
簡介

FirstString Research, Inc.是總公司設在美國的生物科技企業,對創傷預防、發炎抑制、傷口護理、複合組織再生的治療藥, 或在醫療應用的開發平台上,利用細胞間傳遞信息及細胞間黏合研究。該公司進行創傷(糖尿病足部潰傷、靜脈性腳潰瘍等)的治療藥相關臨床試驗。

本報告提供FirstString Research, Inc.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

FirstString Research, Inc.的基本資料

  • FirstString Research, Inc.概要
  • 主要資訊
  • 企業資料

FirstString Research, Inc.:R&D概要

  • 主要的治療範圍

FirstString Research, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

FirstString Research, Inc.:開發中產品概況

  • 後期階段的開發中產品
    • 第Ⅲ相的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

FirstString Research, Inc.:藥物簡介

  • Granexin
  • Synthetic Peptide for Acute Lung Injury and Acute Respiratory Distress Syndrome
  • Synthetic Peptide for Cancer
  • Synthetic Peptide for Corneal Healing
  • Synthetic Peptide for Sarcoidosis
  • Synthetic Peptide for Spinal Cord Injuries

FirstString Research, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

FirstString Research, Inc.:最近的開發平台資訊

FirstString Research, Inc.:開發暫停中的計劃

FirstString Research, Inc.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07109CDB

Summary

Global Markets Direct's, 'FirstString Research, Inc. - Product Pipeline Review - 2015', provides an overview of the FirstString Research, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of FirstString Research, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of FirstString Research, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of FirstString Research, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the FirstString Research, Inc.'s pipeline products

Reasons to buy

  • Evaluate FirstString Research, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of FirstString Research, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the FirstString Research, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of FirstString Research, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of FirstString Research, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of FirstString Research, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • FirstString Research, Inc. Snapshot
    • FirstString Research, Inc. Overview
    • Key Information
    • Key Facts
  • FirstString Research, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • FirstString Research, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • FirstString Research, Inc. - Pipeline Products Glance
    • FirstString Research, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • FirstString Research, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • FirstString Research, Inc. - Drug Profiles
    • Granexin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Acute Lung Injury and Acute Respiratory Distress Syndrome
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Corneal Healing
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Sarcoidosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Synthetic Peptide for Spinal Cord Injuries
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • FirstString Research, Inc. - Pipeline Analysis
    • FirstString Research, Inc. - Pipeline Products by Route of Administration
    • FirstString Research, Inc. - Pipeline Products by Molecule Type
  • FirstString Research, Inc. - Recent Pipeline Updates
  • FirstString Research, Inc. - Dormant Projects
  • FirstString Research, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • FirstString Research, Inc., Key Information
  • FirstString Research, Inc., Key Facts
  • FirstString Research, Inc. - Pipeline by Indication, 2015
  • FirstString Research, Inc. - Pipeline by Stage of Development, 2015
  • FirstString Research, Inc. - Monotherapy Products in Pipeline, 2015
  • FirstString Research, Inc. - Phase III, 2015
  • FirstString Research, Inc. - Preclinical, 2015
  • FirstString Research, Inc. - Pipeline by Route of Administration, 2015
  • FirstString Research, Inc. - Pipeline by Molecule Type, 2015
  • FirstString Research, Inc. - Recent Pipeline Updates, 2015
  • FirstString Research, Inc. - Dormant Developmental Projects,2015

List of Figures

  • FirstString Research, Inc. - Pipeline by Top 10 Indication, 2015
  • FirstString Research, Inc. - Pipeline by Stage of Development, 2015
  • FirstString Research, Inc. - Monotherapy Products in Pipeline, 2015
  • FirstString Research, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • FirstString Research, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top